Hernández, S.; Navas, E.; Aznar-Lou, I.; Ciruela, P.; García-García, J.J.; Moraga-Llop, F.; Muñoz-Almagro, C.; Codina, G.; F. de Sevilla, M.; González-Peris, S.;
et al. Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study. Vaccines 2020, 8, 387.
https://doi.org/10.3390/vaccines8030387
AMA Style
Hernández S, Navas E, Aznar-Lou I, Ciruela P, García-García JJ, Moraga-Llop F, Muñoz-Almagro C, Codina G, F. de Sevilla M, González-Peris S,
et al. Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study. Vaccines. 2020; 8(3):387.
https://doi.org/10.3390/vaccines8030387
Chicago/Turabian Style
Hernández, Sergi, Encarna Navas, Ignacio Aznar-Lou, Pilar Ciruela, Juan José García-García, Fernando Moraga-Llop, Carmen Muñoz-Almagro, Gemma Codina, Mariona F. de Sevilla, Sebastià González-Peris,
and et al. 2020. "Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study" Vaccines 8, no. 3: 387.
https://doi.org/10.3390/vaccines8030387
APA Style
Hernández, S., Navas, E., Aznar-Lou, I., Ciruela, P., García-García, J. J., Moraga-Llop, F., Muñoz-Almagro, C., Codina, G., F. de Sevilla, M., González-Peris, S., Esteva, C., Planes, A. M., Izquierdo, C., Martínez-Osorio, J., Campins, M., Uriona, S., Salleras, L., Serrano-Blanco, A., Jané, M.,
& Domínguez, Á.
(2020). Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study. Vaccines, 8(3), 387.
https://doi.org/10.3390/vaccines8030387
